For cancer, the percentage of people (the number of people out of 100) diagnosed with cancer who have not died of cancer within five years of diagnosis.
the percentage of people with a given cancer who are expected to survive 5 years or longer after diagnosis. Five-year survival rates are based on the most recent information available, but they may include information from patients treated several years earlier. These numbers do not take into account advances in treatment that have often occurred. They are not helpful in predicting an individual case. They only paint a very general picture of how people in the past have done with the same type of cancer. See also relative 5-year survival rate.
The percentage of people with a given cancer who are expected to survive five years or longer with the disease. Five-year survival rates, while statistically valid, should not be seen as a predictor in individual cases.
The percentage of patients diagnosed with a disease who are alive five years after diagnosis of their disease.
(five yeer ser-VIE-vul rate) Describes the percentage of patients who live at least five years after their cancer is diagnosed. Five-year relative survival rates exclude patients dying of other diseases, which means that anyone who died of another cause, such as heart disease, is not counted.
The percentage of people alive five years after being diagnosed with skin cancer.
The number of people who live at least five years after their breast cancer is diagnosed.
the 5-year survival rate refers to the percent of patients who live at least 5 years after their cancer is diagnosed. Five-year survival rates are used to produce a standard way of discussing prognosis. Five-year relative survival rates exclude from the calculations patients dying of other diseases, and are considered to be a more accurate way to describe the prognosis for patients with a particular type and stage of cancer. Of course, 5-year survival rates are based on patients diagnosed and initially treated more than 5 years ago. Improvements in treatment often result in a more favorable outlook for recently diagnosed patients.